136 related articles for article (PubMed ID: 37679872)
21. Invasive nodal evaluation prior to stereotactic ablative radiation for non-small cell lung cancer.
Harris JP; Nwachukwu C; Qian Y; Pollom E; Loo BW; Das M; Diehn M
Lung Cancer; 2018 Oct; 124():76-85. PubMed ID: 30268484
[TBL] [Abstract][Full Text] [Related]
22. The impact of histology in the outcomes of patients with early-stage non-small cell lung cancer (NSCLC) treated with stereotactic body radiation therapy (SBRT) and adjuvant chemotherapy.
Ernani V; Appiah AK; Baine MJ; Smith LM; Ganti AK
Cancer Treat Res Commun; 2020; 24():100197. PubMed ID: 32777751
[TBL] [Abstract][Full Text] [Related]
23. Video-assisted thoracoscopic lobectomy versus stereotactic radiotherapy for stage I lung cancer.
Hamaji M; Chen F; Matsuo Y; Kawaguchi A; Morita S; Ueki N; Sonobe M; Nagata Y; Hiraoka M; Date H
Ann Thorac Surg; 2015 Apr; 99(4):1122-9. PubMed ID: 25661580
[TBL] [Abstract][Full Text] [Related]
24. Stereotactic Body Radiotherapy Versus Delayed Surgery for Early-stage Non-small-cell Lung Cancer.
Mayne NR; Lin BK; Darling AJ; Raman V; Patel DC; Liou DZ; D'Amico TA; Yang CJ
Ann Surg; 2020 Dec; 272(6):925-929. PubMed ID: 33074904
[TBL] [Abstract][Full Text] [Related]
25. Increased Utilization of Stereotactic Body Radiotherapy is Associated with Decreased Disparities and Improved Survival for Early-Stage NSCLC.
Ganesh A; Korpics M; Pasquinelli M; Feldman L; Spiotto M; Koshy M
Clin Lung Cancer; 2023 Jan; 24(1):60-71. PubMed ID: 36289032
[TBL] [Abstract][Full Text] [Related]
26. Comparison of outcomes following stereotactic body radiotherapy for non-small cell lung cancer in patients with and without pathological confirmation.
Haidar YM; Rahn DA; Nath S; Song W; Bazhenova L; Makani S; Fuster MM; Sandhu AP
Ther Adv Respir Dis; 2014 Feb; 8(1):3-12. PubMed ID: 24334338
[TBL] [Abstract][Full Text] [Related]
27. Incidental mediastinal dose does not explain low mediastinal node recurrence rates in patients with early-stage NSCLC treated with stereotactic body radiotherapy.
Rwigema JC; Chen AM; Wang PC; Lee JM; Garon E; Lee P
Clin Lung Cancer; 2014 Jul; 15(4):287-93. PubMed ID: 24594401
[TBL] [Abstract][Full Text] [Related]
28. Comparison of Long-term Survival of Patients With Early-Stage Non-Small Cell Lung Cancer After Surgery vs Stereotactic Body Radiotherapy.
Chi A; Fang W; Sun Y; Wen S
JAMA Netw Open; 2019 Nov; 2(11):e1915724. PubMed ID: 31747032
[TBL] [Abstract][Full Text] [Related]
29. Improved Survival of Stage I Non-Small Cell Lung Cancer: A VA Central Cancer Registry Analysis.
Boyer MJ; Williams CD; Harpole DH; Onaitis MW; Kelley MJ; Salama JK
J Thorac Oncol; 2017 Dec; 12(12):1814-1823. PubMed ID: 28951090
[TBL] [Abstract][Full Text] [Related]
30. Prior Treatment for Non-small Cell Lung Cancer Is Associated With Improved Survival in Patients who Undergo Definitive Stereotactic Body Radiation Therapy for a Subsequent Lung Malignancy: A Retrospective Multivariate and Matched Pair Analysis.
Farrugia MK; Jun Ma S; Hennon MW; Nwogu CE; Dexter EU; Picone AL; Demmy TL; Gomez-Suescun JA; Fung-Kee-Fung S; Yendamuri SS; Singh AK
Am J Clin Oncol; 2021 Jan; 44(1):18-23. PubMed ID: 33264123
[TBL] [Abstract][Full Text] [Related]
31. Discontinuous stereotactic body radiotherapy schedule increases overall survival in early-stage non-small cell lung cancer.
Duvergé L; Bondiau PY; Claude L; Supiot S; Vaugier L; Thillays F; Doyen J; Ricordel C; Léna H; Bellec J; Chajon E; de Crevoisier R; Castelli J
Lung Cancer; 2021 Jul; 157():100-108. PubMed ID: 34016489
[TBL] [Abstract][Full Text] [Related]
32. A Propensity-Matched Analysis of Outcomes of Patients with Clinical Stage I Non-Small Cell Lung Cancer Treated surgically or with stereotactic radiotherapy: A Meta-Analysis.
Wen SW; Han L; Lv HL; Xu YZ; Li ZH; Wang MB; Zhu YG; Su P; Tian ZQ; Zhang YF
J Invest Surg; 2019 Jan; 32(1):27-34. PubMed ID: 28985095
[TBL] [Abstract][Full Text] [Related]
33. Local control for clinical stage I non-small cell lung cancer treated with 5-fraction stereotactic body radiation therapy is not associated with treatment schedule.
Samson P; Rehman S; Juloori A; DeWees T; Roach M; Bradley J; Videtic GMM; Stephans K; Robinson C
Pract Radiat Oncol; 2018; 8(6):404-413. PubMed ID: 29907514
[TBL] [Abstract][Full Text] [Related]
34. Mortality after radiotherapy or surgery in the treatment of early-stage non-small-cell lung cancer: a population-based data analysis in the clinical cancer registry of Brandenburg-Berlin.
Müller JA; Vordermark D; Medenwald D
Strahlenther Onkol; 2023 Jul; 199(7):658-667. PubMed ID: 36912978
[TBL] [Abstract][Full Text] [Related]
35. A National Cancer Database Analysis of Radiofrequency Ablation versus Stereotactic Body Radiotherapy in Early-Stage Non-Small Cell Lung Cancer.
Lam A; Yoshida EJ; Bui K; Fernando D; Nelson K; Abi-Jaoudeh N
J Vasc Interv Radiol; 2018 Sep; 29(9):1211-1217.e1. PubMed ID: 30061058
[TBL] [Abstract][Full Text] [Related]
36. Three- Versus Five-Fraction Regimens of Stereotactic Body Radiotherapy for Peripheral Early-Stage Non-Small-Cell Lung Cancer: A Two-Institution Propensity Score-Matched Analysis.
Ma SJ; Cummings M; Serra LM; Syed YA; Hermann GM; Chen Y; Milano MT; Singh AK; Gomez-Suescun JA; Singh DP
Clin Lung Cancer; 2018 May; 19(3):e297-e302. PubMed ID: 29254649
[TBL] [Abstract][Full Text] [Related]
37. Stereotactic body radiation therapy for medically inoperable early-stage lung cancer: Tata Memorial Hospital perspective and practice recommendations.
Agarwal JP; Pilar A; Mummudi N; Gupta M; Laskar SG; Pathak RS; Tibdewal AR; Kinhikar R; Ghadi Y; Tandon S; Purandare N; Prabhash K; Patil V
Indian J Cancer; 2020; 57(1):18-24. PubMed ID: 31929233
[TBL] [Abstract][Full Text] [Related]
38. Lack of an association between marital status and survival in patients receiving stereotactic body radiotherapy for early-stage non-small-cell lung cancer.
Kishi N; Matsuo Y; Hanazawa H; Iizuka Y; Mizowaki T
PLoS One; 2022; 17(6):e0269463. PubMed ID: 35657816
[TBL] [Abstract][Full Text] [Related]
39. Surgery versus stereotactic body radiotherapy for clinical stage I non-small-cell lung cancer: propensity score-matching analysis including the ratio of ground glass nodules.
Tomita N; Okuda K; Osaga S; Miyakawa A; Nakanishi R; Shibamoto Y
Clin Transl Oncol; 2021 Mar; 23(3):638-647. PubMed ID: 32705493
[TBL] [Abstract][Full Text] [Related]
40. Adjuvant Systemic Therapy in Patients With Early-Stage NSCLC Treated With Stereotactic Body Radiation Therapy.
Ernani V; Appiah AK; Marr A; Zhang C; Zhen W; Smith LM; Ganti AK
J Thorac Oncol; 2019 Mar; 14(3):475-481. PubMed ID: 30503890
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
